{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:06:29Z","timestamp":1777503989645,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,2]],"date-time":"2012-08-02T00:00:00Z","timestamp":1343865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1472-6947-12-83","type":"journal-article","created":{"date-parts":[[2012,8,2]],"date-time":"2012-08-02T12:21:42Z","timestamp":1343910102000},"source":"Crossref","is-referenced-by-count":19,"title":["Decision-making in healthcare: a practical application of partial least square path modelling to coverage of newborn screening programmes"],"prefix":"10.1186","volume":"12","author":[{"given":"Katharina E","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,2]]},"reference":[{"key":"526_CR1","first-page":"1","volume":"91","author":"C Sorenson","year":"2010","unstructured":"Sorenson C: Use of comparative effectiveness research in drug coverage and pricing decisions: a six-country comparison. Issue Brief (Commonw Fund). 2010, 91: 1-14.","journal-title":"Issue Brief (Commonw Fund)"},{"key":"526_CR2","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1136\/bmj.329.7472.972","volume":"329","author":"RS Taylor","year":"2004","unstructured":"Taylor RS, Drummond MF, Salkeld G, Sullivan SD: Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ. 2004, 329: 972-975. 10.1136\/bmj.329.7472.972.","journal-title":"BMJ"},{"key":"526_CR3","volume-title":"Decision Making in Health Care","author":"GB Chapman","year":"2000","unstructured":"Chapman GB, Sonnenberg FA: Decision Making in Health Care. 2000, Cambridge University Press, Cambridge"},{"key":"526_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/1472-6963-8-194","volume":"8","author":"WH Rogowski","year":"2008","unstructured":"Rogowski WH, Hartz SC, John JH: Clearing up the hazy road from bench to bedside: a framework for integrating the fourth hurdle into translational medicine. BMC Health Serv Res. 2008, 8: 194-10.1186\/1472-6963-8-194.","journal-title":"BMC Health Serv Res"},{"key":"526_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/wbro\/14.1.137","volume":"14","author":"JL Guasch","year":"1999","unstructured":"Guasch JL, Hahn RW: The costs and benefits of regulation: implications for developing countries. World Bank Research Observer. 1999, 14: 137-158. 10.1093\/wbro\/14.1.137.","journal-title":"World Bank Research Observer"},{"key":"526_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.healthpol.2009.09.014","volume":"94","author":"B Wettermark","year":"2010","unstructured":"Wettermark B, Godman B, Neovius M, Hedberg N, Mellgren TO, Kahan T: Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment. Health Policy. 2010, 94: 221-229. 10.1016\/j.healthpol.2009.09.014.","journal-title":"Health Policy"},{"key":"526_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.healthpol.2006.02.004","volume":"79","author":"J Lundkvist","year":"2006","unstructured":"Lundkvist J, Jonsson B, Rehnberg C: The costs and benefits of regulations for reimbursement of new drugs. Health Policy. 2006, 79: 337-344. 10.1016\/j.healthpol.2006.02.004.","journal-title":"Health Policy"},{"key":"526_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2165\/11586420-000000000-00000","volume":"29","author":"T Stafinski","year":"2011","unstructured":"Stafinski T, Menon D, Philippon DJ, McCabe CJ: Health technology funding decision-making processes around the world: the same, yet different. PharmacoEconomics. 2011, 29: 475-495. 10.2165\/11586420-000000000-00000.","journal-title":"PharmacoEconomics"},{"key":"526_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.healthpol.2007.09.007","volume":"86","author":"L Vuorenkoski","year":"2008","unstructured":"Vuorenkoski L, Toiviainen H, Hemminki E: Decision-making in priority setting for medicines \u2013 a review of empirical studies. Health Policy. 2008, 86: 1-9. 10.1016\/j.healthpol.2007.09.007.","journal-title":"Health Policy"},{"key":"526_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.healthpol.2005.08.008","volume":"77","author":"HA Dakin","year":"2006","unstructured":"Dakin HA, Devlin NJ, Odeyemi IA: 'Yes', 'No' or 'Yes, but'? Multinomial modelling of NICE decision-making. Health Policy. 2006, 77: 352-367. 10.1016\/j.healthpol.2005.08.008.","journal-title":"Health Policy"},{"key":"526_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/hec.864","volume":"13","author":"N Devlin","year":"2004","unstructured":"Devlin N, Parkin D: Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ. 2004, 13: 437-452. 10.1002\/hec.864.","journal-title":"Health Econ"},{"key":"526_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/hec.1483","volume":"19","author":"L Segal","year":"2009","unstructured":"Segal L, Dalziel K, Duncan M: Fixing the game: are between-silo differences in funding arrangements handicapping some interventions and giving others a head-start?. Health Econ. 2009, 19: 449-465.","journal-title":"Health Econ"},{"key":"526_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1177\/0272989X08315247","volume":"28","author":"AH Harris","year":"2008","unstructured":"Harris AH, Hill SR, Chin G, Li JJ, Walkom E: The role of value for money in public insurance coverage decisions for drugs in Australia: a retrospective analysis 1994\u20132004. Med Decis Making. 2008, 28: 713-722. 10.1177\/0272989X08315247.","journal-title":"Med Decis Making"},{"key":"526_CR14","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1001\/jama.2009.1409","volume":"302","author":"FM Clement","year":"2009","unstructured":"Clement FM, Harris A, Jing JL, Yong K, Lee KM, Manns BJ: Using effectiveness and cost-effectiveness to make drug coverage decisions: A comparison of Britain, Australia, and Canada. JAMA. 2009, 302: 1437-1443. 10.1001\/jama.2009.1409.","journal-title":"JAMA"},{"key":"526_CR15","first-page":"1","volume":"12","author":"P Kanavos","year":"2010","unstructured":"Kanavos P, Nicod E, van den Aardweg S, Pomedli S: The impact of health technology assessments: an international comparison. Euro Observer. 2010, 12: 1-7.","journal-title":"Euro Observer"},{"key":"526_CR16","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1200\/JCO.2009.26.2758","volume":"28","author":"AR Mason","year":"2010","unstructured":"Mason AR, Drummond MF, Ramsey S, Campbell J, Raisch D: Comparison of Anticancer Drug Coverage Decisions in the United States and United Kingdom: Does the Evidence Support the Rhetoric?. J Clin Oncol. 2010, 28: 3234-3238. 10.1200\/JCO.2009.26.2758.","journal-title":"J Clin Oncol"},{"key":"526_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1377\/hlthaff.17.5.50","volume":"17","author":"N Daniels","year":"1998","unstructured":"Daniels N, Sabin J: The ethics of accountability in managed care reform. Health Aff. 1998, 17: 50-64. 10.1377\/hlthaff.17.5.50.","journal-title":"Health Aff"},{"key":"526_CR18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jval.2010.10.036","volume":"14","author":"S Erntoft","year":"2011","unstructured":"Erntoft S: Pharmaceutical priority setting and the use of health economic evaluations: a systematic literature review. Value Health. 2011, 14: 587-599. 10.1016\/j.jval.2010.10.036.","journal-title":"Value Health"},{"key":"526_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2753\/MTP1069-6679190202","volume":"19","author":"J Hair","year":"2011","unstructured":"Hair J, Ringle CM, Sarstedt M: PLS-SEM: Indeed a Silver Bullet. J Marketing Theory Pract. 2011, 19: 139-152. 10.2753\/MTP1069-6679190202.","journal-title":"J Marketing Theory Pract"},{"key":"526_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1108\/S1474-7979(2009)0000020014","volume-title":"Advances in International Marketing","author":"J Henseler","year":"2009","unstructured":"Henseler J, Ringle CM, Sinkovics RR: The use of partial least squares path modeling in international marketing. Advances in International Marketing. Edited by: Sinkovics RR, Ghauri PN. 2009, Emerald, Bingley, 277-320. Volume 20","edition":"Volume 20"},{"key":"526_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/heapro\/dam002","volume":"22","author":"AM Downey","year":"2007","unstructured":"Downey AM, Sharp DJ: Why do managers allocate resources to workplace health promotion programmes in countries with national health coverage?. Health Promot Int. 2007, 22: 102-111. 10.1093\/heapro\/dam002.","journal-title":"Health Promot Int"},{"key":"526_CR22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.dss.2008.06.004","volume":"46","author":"Z Walter","year":"2008","unstructured":"Walter Z, Lopez MS: Physician acceptance of information technologies: role of perceived threat to professional autonomy. Decis Support Syst. 2008, 46: 206-215. 10.1016\/j.dss.2008.06.004.","journal-title":"Decis Support Syst"},{"key":"526_CR23","unstructured":"Ringle CM, Wende S, Will A: SmartPLS 2.0. , , , http:\/\/www.smartpls.com"},{"key":"526_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.healthpol.2011.03.002","volume":"101","author":"KE Fischer","year":"2011","unstructured":"Fischer KE, Leidl R, Rogowski WH: A structured tool to analyse coverage decisions: development and feasibility test in the field of cancer screening and prevention. Health Policy. 2011, 101: 290-299. 10.1016\/j.healthpol.2011.03.002.","journal-title":"Health Policy"},{"key":"526_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11135-010-9364-2","volume":"45","author":"P Lovaglio","year":"2011","unstructured":"Lovaglio P: Model building and estimation strategies for implementing the Balanced Scorecard in Health sector. Qual Quant. 2011, 45: 199-212. 10.1007\/s11135-010-9364-2.","journal-title":"Qual Quant"},{"key":"526_CR26","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1081\/SAC-120023882","volume":"32","author":"E Vigneau","year":"2003","unstructured":"Vigneau E, Qannari E: Clustering of Variables Around Latent Components. Communications in Statistics - Simulation and Computation. 2003, 32: 1131-1150. 10.1081\/SAC-120023882.","journal-title":"Communications in Statistics - Simulation and Computation"},{"key":"526_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1017\/S0266462306050781","volume":"22","author":"J Hutton","year":"2006","unstructured":"Hutton J, McGrath C, Frybourg JM, Tremblay M, Bramley-Harker E, Henshall C: Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems). Int J Technol Assess Health Care. 2006, 22: 10-18.","journal-title":"Int J Technol Assess Health Care"},{"key":"526_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0140-6736(09)60137-9","volume":"373","author":"G Persad","year":"2009","unstructured":"Persad G, Wertheimer A, Emanuel EJ: Principles for allocation of scarce medical interventions. Lancet. 2009, 373: 423-431. 10.1016\/S0140-6736(09)60137-9.","journal-title":"Lancet"},{"key":"526_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/jme.26.5.323","volume":"26","author":"R Cookson","year":"2000","unstructured":"Cookson R, Dolan P: Principles of justice in health care rationing. J Med Ethics. 2000, 26: 323-329. 10.1136\/jme.26.5.323.","journal-title":"J Med Ethics"},{"key":"526_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1478-7547-4-14","volume":"4","author":"R Baltussen","year":"2006","unstructured":"Baltussen R, Niessen L: Priority setting of health interventions: the need for multi-criteria decision analysis. Cost Eff Resour Alloc. 2006, 4: 14-10.1186\/1478-7547-4-14.","journal-title":"Cost Eff Resour Alloc"},{"key":"526_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1472-6963-9-43","volume":"9","author":"SL Sibbald","year":"2009","unstructured":"Sibbald SL, Singer PA, Upshur R, Martin DK: Priority setting: what constitutes success? A conceptual framework for successful priority setting. BMC Health Serv Res. 2009, 9: 43-10.1186\/1472-6963-9-43.","journal-title":"BMC Health Serv Res"},{"key":"526_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.healthpol.2010.10.012","volume":"102","author":"O Golan","year":"2011","unstructured":"Golan O, Hansen P, Kaplan G, Tal O: Health technology prioritization: which criteria for prioritizing new technologies and what are their relative weights?. Health Policy. 2011, 102: 126-135. 10.1016\/j.healthpol.2010.10.012.","journal-title":"Health Policy"},{"key":"526_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.socscimed.2005.11.049","volume":"63","author":"CR Mitton","year":"2006","unstructured":"Mitton CR, McMahon M, Morgan S, Gibson J: Centralized drug review processes: are they fair?. Soc Sci Med. 2006, 63: 200-211. 10.1016\/j.socscimed.2005.11.049.","journal-title":"Soc Sci Med"},{"key":"526_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1586\/erp.10.82","volume":"11","author":"D Menon","year":"2011","unstructured":"Menon D, Stafinski T: Role of patient and public participation in health technology assessment and coverage decisions. Expert Rev Pharmacoecon Outcomes Res. 2011, 11: 75-89. 10.1586\/erp.10.82.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"526_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.healthpol.2006.07.009","volume":"82","author":"J Abelson","year":"2007","unstructured":"Abelson J, Giacomini M, Lehoux P, Gauvin FP: Bringing 'the public' into health technology assessment and coverage policy decisions: from principles to practice. Health Policy. 2007, 82: 37-50. 10.1016\/j.healthpol.2006.07.009.","journal-title":"Health Policy"},{"key":"526_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/hec.1133","volume":"16","author":"S Bryan","year":"2007","unstructured":"Bryan S, Williams I, McIver S: Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals. Health Econ. 2007, 16: 179-193. 10.1002\/hec.1133.","journal-title":"Health Econ"},{"key":"526_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1017\/S0266462311000468","volume":"27","author":"KE Fischer","year":"2011","unstructured":"Fischer KE, Grosse SD, Rogowski W: The Role of Health Technology Assessment in Coverage Decisions on Newborn Screening. Int J Technol Assess Health Care. 2011, 27: 305-312. 10.1017\/S0266462311000444.","journal-title":"Int J Technol Assess Health Care"},{"key":"526_CR38","volume-title":"SAS version 9.2","author":"SAS Institute Inc","year":"2008","unstructured":"SAS Institute Inc: SAS version 9.2. 2008, Cary, NC, USA"},{"key":"526_CR39","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/978-3-540-32827-8_30","volume-title":"Handbook of Partial Least Squares","author":"O G\u00f6tz","year":"2010","unstructured":"G\u00f6tz O, Liehr-Gobbers K, Krafft M: Evaluation of structural equation models using the partial least squares (PLS) approach. Handbook of Partial Least Squares. Edited by: Esposito Vinzi V, Chin WW, Henseler J, Wang H. 2010, Springer Handbooks of Computational Statistics, Springer Berlin Heidelberg, 691-711."},{"key":"526_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.csda.2004.03.005","volume":"48","author":"M Tenenhaus","year":"2005","unstructured":"Tenenhaus M, Vinzi VE, Chatelin Y-M, Lauro C: PLS path modeling. Computational Statistics & Data Analysis. 2005, 48: 159-205. 10.1016\/j.csda.2004.03.005.","journal-title":"Computational Statistics & Data Analysis"},{"key":"526_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/acprof:oso\/9780199547494.003.06","volume-title":"Economic evaluation in Child Health","author":"SD Grosse","year":"2009","unstructured":"Grosse SD: Economic evaluations of newborn screening. Economic evaluation in Child Health. Edited by: Ungar WJ. 2009, Oxford University Press, New York, 113-132."},{"key":"526_CR42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/00313020701813743","volume":"40","author":"B Wilcken","year":"2008","unstructured":"Wilcken B, Wiley V: Newborn screening. Pathology. 2008, 40: 104-115. 10.1080\/00313020701813743.","journal-title":"Pathology"},{"key":"526_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/(SICI)1097-0266(199902)20:2<195::AID-SMJ13>3.0.CO;2-7","volume":"20","author":"J Hulland","year":"1999","unstructured":"Hulland J: Use of partial least squares (PLS) in strategic management research: a review of four recent studies. Strateg Manag J. 1999, 20: 195-204. 10.1002\/(SICI)1097-0266(199902)20:2<195::AID-SMJ13>3.0.CO;2-7.","journal-title":"Strateg Manag J"},{"key":"526_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1787\/9789264016224-en","volume-title":"Health Technologies and Decision Making","author":"OECD: Chapter 4","year":"2005","unstructured":"OECD: Chapter 4: Decision making and implementation: an analysis of survey results. Health Technologies and Decision Making. 2005, , Paris, 71-94."},{"key":"526_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1524-4733.2008.00441.x","volume":"12","author":"M Barbieri","year":"2009","unstructured":"Barbieri M, Hawkins N, Sculpher MJ: Who Does the Numbers? The Role of Third-Party Technology Assessment to Inform Health Systems' Decision-Making about the Funding of Health Technologies. Value Health. 2009, 12: 193-201. 10.1111\/j.1524-4733.2008.00441.x.","journal-title":"Value Health"},{"key":"526_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/CEOR.S14407","volume":"3","author":"T Stafinski","year":"2011","unstructured":"Stafinski T, Menon D, Davis C, McCabe C: Role of centralized review processes for making reimbursement decisions on new health technologies in Europe. Clinicoecon Outcomes Res. 2011, 3: 117-186.","journal-title":"Clinicoecon Outcomes Res"},{"key":"526_CR47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.zefq.2011.04.012","volume":"105","author":"I Scholl","year":"2011","unstructured":"Scholl I, Koelewijn-van Loon M, Sepucha K, Elwyn G, Legare F, Harter M, Dirmaier J: Measurement of shared decision making \u2013 a review of instruments. Z Evid Fortbild Qual Gesundhwes. 2011, 105: 313-324. 10.1016\/j.zefq.2011.04.012.","journal-title":"Z Evid Fortbild Qual Gesundhwes"},{"key":"526_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.eswa.2009.05.021","volume":"37","author":"WW Wu","year":"2010","unstructured":"Wu WW: Linking Bayesian networks and PLS path modeling for causal analysis. Expert Syst Appl. 2010, 37: 134-139. 10.1016\/j.eswa.2009.05.021.","journal-title":"Expert Syst Appl"},{"key":"526_CR49","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1016\/j.csda.2006.12.004","volume":"51","author":"E Jakobowicz","year":"2007","unstructured":"Jakobowicz E, Derquenne C: A modified PLS path modeling algorithm handling reflective categorical variables and a new model building strategy. Comput Stat Data An. 2007, 51: 3666-3678. 10.1016\/j.csda.2006.12.004.","journal-title":"Comput Stat Data An"},{"key":"526_CR50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1108\/S1548-6435(2010)0000007011","volume-title":"Review of Marketing Research","author":"EE Rigdon","year":"2010","unstructured":"Rigdon EE, Ringle CM, Sarstedt M: Structural modeling of heterogeneous data with partial least squares. Review of Marketing Research. Edited by: Malhotra NK. 2010, Emerald Group Publishing Limited, Armonk, 255-296. Volume 7","edition":"Volume 7"},{"key":"526_CR51","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jhealeco.2010.12.009","volume":"30","author":"P Deb","year":"2011","unstructured":"Deb P, Gallo WT, Ayyagari P, Fletcher JM, Sindelar JL: The effect of job loss on overweight and drinking. J Health Econ. 2011, 30: 317-327. 10.1016\/j.jhealeco.2010.12.009.","journal-title":"J Health Econ"},{"key":"526_CR52","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1472-6963-10-131","volume":"10","author":"SL Sibbald","year":"2010","unstructured":"Sibbald SL, Gibson JL, Singer PA, Upshur R, Martin DK: Evaluating priority setting success in healthcare: a pilot study. BMC Health Serv Res. 2010, 10: 131-10.1186\/1472-6963-10-131.","journal-title":"BMC Health Serv Res"},{"key":"526_CR53","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jme.2008.024430","volume":"35","author":"A Rid","year":"2009","unstructured":"Rid A: Justice and procedure: how does 'accountability for reasonableness' result in fair limit-setting decisions?. J Med Ethics. 2009, 35: 12-16. 10.1136\/jme.2008.024430.","journal-title":"J Med Ethics"},{"key":"526_CR54","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.socscimed.2010.01.036","volume":"70","author":"FP Gauvin","year":"2010","unstructured":"Gauvin FP, Abelson J, Giacomini M, Eyles J, Lavis JN: 'It all depends': conceptualizing public involvement in the context of health technology assessment agencies. Sco Sci Med. 2010, 70: 1518-1526.","journal-title":"Sco Sci Med"},{"key":"526_CR55","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.healthpol.2005.08.006","volume":"77","author":"M McMahon","year":"2006","unstructured":"McMahon M, Morgan S, Mitton C: The Common Drug Review: a NICE start for Canada?. Health Policy. 2006, 77: 339-351. 10.1016\/j.healthpol.2005.08.006.","journal-title":"Health Policy"},{"key":"526_CR56","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1377\/hlthaff.25.2.337","volume":"25","author":"SG Morgan","year":"2006","unstructured":"Morgan SG, McMahon M, Mitton C, Roughead E, Kirk R, Kanavos P, Menon D: Centralized drug review processes in Australia, Canada, New Zealand, and the United Kingdom. Health Aff (Millwood). 2006, 25: 337-347. 10.1377\/hlthaff.25.2.337.","journal-title":"Health Aff (Millwood)"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6947-12-83\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-12-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-12-83","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-12-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T15:10:29Z","timestamp":1548169829000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/1472-6947-12-83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,2]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["526"],"URL":"https:\/\/doi.org\/10.1186\/1472-6947-12-83","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,2]]},"article-number":"83"}}